GREMLIN1 disrupts intestinal epithelial-mesenchymal crosstalk to induce a wnt-dependent ectopic stem cell niche via stromal remodelling
EJ. Mulholland,HL. Belnoue-Davis,GN. Valbuena,N. Gunduz,A. Ligezal,S. Biswasl,E. Gil Vasquez,S. Omwengal,N. Nasreddinl,M. Hodder,LM. Wang,S. Irshad,AS. Ng,LK. Jennings,KS. Midwood,N. Dedi,R. Ridgeway,T. Phesse,JE. East,IPM. Tomlinson,GCG. Davies,O. Sansom,SJ. Leedham
DOI: https://doi.org/10.1101/2024.04.28.591245
2024-04-30
Abstract:In homeostasis, counterbalanced morphogen signalling gradients along the vertical axis of the intestinal mucosa regulate the fate and function of epithelial and stromal cell compartments. Here, we used a disease-positioned mouse, and human tissue, to explore the consequences of pathological Bone Morphogenetic Protein (BMP) signalling dysregulation on epithelial- mesenchymal interaction. Aberrant pan-epithelial expression of the secreted BMP antagonist GREM1, resulted in ectopic crypt formation with lineage tracing demonstrating the presence of stem/progenitor cells. Isolated epithelial cell expression had no effect on individual cell fate, indicating an intercompartmental impact of mucosal-wide BMP antagonism. Treatment with a novel anti-Grem1 antibody abrogated the polyposis phenotype, and triangulation of specific pathway inhibitors defined a pathological sequence of events, with wnt-ligand dependent ectopic stem cell niches formed through stromal remodelling following BMP disruption. These data support an emerging co-evolutionary model of intestinal cell compartmentalisation based on bidirectional regulation of epithelial-mesenchymal cell fate and function.
Cancer Biology